Abstract
SHS investigation development is considered from the geographical and historical viewpoint. 3 stages are described. Within Stage 1 the work was carried out in the Department of the Institute of Chemical Physics in Chernogolovka where the scientific discovery had been made. At Stage 2 the interest to SHS arose in different cities and towns of the former USSR. Within Stage 3 SHS entered the international scene. Now SHS processes and products are being studied in more than 50 countries.
Abstract
Ever since the association between cancer and thrombosis was reported in the early 19th century multiple studies have confirmed the relationship between cancer and thrombosis. Cancer patients, especially in the first few months after diagnosis and those with distant metastasis, have an elevated risk for VTE, and conversely, the risk of cancer diagnosis is high within the first 2 years of idiopathic VTE. VTE has an important impact on the prognosis of cancer patients. Thrombosis was the second leading cause of death (9.2%) after the cancer progression (70.9%) itself. The risks of recurrent VTE and bleeding are higher in patients with cancer-associated venous thrombosis than patients with venous thrombosis but without cancer.
Keywords:
Anticoagulants, Cancer-associated thrombosis, Cancer costs, Cancer treatment, Coagulation in cancer, Hypercoagulability, Idiopathic VTE, Malignancy, Pulmonary embolism, Risks for VTE, Thrombosis, Trousseau syndrome, Venous thromboembolism, VTE prophylaxis, VTE treatment.
Recommended Chapters
We recommend
Authors:Bentham Science Books